Rare diseases
Investigational molecules
Locations
Belatacept Dose Reduction Safety in Kidney Transplant Recipients with a Well-Matched Donor
AustriaEIK1005 Alone and with Pembrolizumab for Advanced Solid Tumors in Patients with MSI-H or dMMR Tumors
AustriaAUR200 for Patients with Generalized Myasthenia Gravis
DenmarkPumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%
AustriaNeoadjuvant Sacituzumab Govitecan and Pembrolizumab for Patients with Clinical Stage II-III Triple-Negative Early Breast Cancer
GermanyStudy of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma
AustriaDermatophagoides farinae, Dermatophagoides pteronyssinus, and Lepidoglyphus destructor Immunotherapy for Allergic Rhinitis and Rhinoconjunctivitis in Patients With or Without Mild Asthma
SpainLetrozole During IVF/ICSI for Women with Endometriosis
BelgiumQTX-2101 and Arsenic Trioxide in Adult Patients With Acute Promyelocytic Leukemia
FranceOpen-Label Extension Study of ATH434-DP2 in Patients with Multiple System Atrophy
FranceLerodalcibep for Heterozygous Familial Hypercholesterolemia in Children and Adolescents 6 to 17 Years Old
NorwayObrixtamig, Carboplatin, and Etoposide for First-Line Treatment of Advanced Extrapulmonary Neuroendocrine Carcinoma in DLL3-Positive Patients
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
